After participating in this educational activity, attendees should be able to:
1| Discuss the evidence supporting the Class 1A designation provided to CCTA in the stable setting.
2| Review the evolving evidence supporting the integration of FFRct and recent investigations exploring plaque quantification on CCTA.
3| Highlight the opportunities to investigate the role of CCTA in helping plan PCI

Jonathon Leipsic, MD, FRPCP
Professor of Radiology
University of British Columbia

Faculty Disclosure

The design and content of Baystate Continuing Interprofessional Education (CE) activities support quality improvement in healthcare and provide fair and balanced views of therapeutic options. Any relevant financial relationships are mitigated prior to the educational activity.

Dr. Leipsic has a financial relationships and is a consultant with Heartflow, Circle CVI, and Arineta.  All of the relevant financial relationships listed for this individual have been mitigated.                       

Accreditation Statement
In support of improving patient care, Baystate Health is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

Baystate Continuing Interprofessional Education designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM.  Physicians should only claim the credit commensurate with the extent of their participation in the activity.

Session date: 
10/11/2023 - 8:00am to 9:00am EDT
Baystate Medical Center
759 Chestnut St
Springfield, MA 01199
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 BCIPE Instructional Hours

Please login or register to take this course.